Markus Reindl mainly investigates Immunology, Multiple sclerosis, Pathology, Neuromyelitis optica and Myelin oligodendrocyte glycoprotein. Immunology and Differential diagnosis are commonly linked in his work. His Multiple sclerosis research is multidisciplinary, incorporating perspectives in Gastroenterology and Internal medicine.
His work is dedicated to discovering how Pathology, Encephalomyelitis are connected with Antibody titer and other disciplines. His studies deal with areas such as Aquaporin 4, Autoantibody, Transverse myelitis, Myelitis and Neurology as well as Neuromyelitis optica. The concepts of his Myelin oligodendrocyte glycoprotein study are interwoven with issues in Cerebrospinal fluid, Myelin basic protein, Encephalitis, Magnetic resonance imaging and Demyelinating Disorder.
Markus Reindl spends much of his time researching Immunology, Multiple sclerosis, Antibody, Pathology and Myelin oligodendrocyte glycoprotein. Markus Reindl interconnects Myelin and Central nervous system in the investigation of issues within Immunology. His work deals with themes such as Internal medicine, Cerebrospinal fluid and Disease, which intersect with Multiple sclerosis.
His research integrates issues of Virology and Oligodendrocyte in his study of Antibody. His biological study spans a wide range of topics, including Inflammation and Magnetic resonance imaging. His Myelin oligodendrocyte glycoprotein study integrates concerns from other disciplines, such as Immunoglobulin G, Myelin basic protein, Demyelinating Disorder, Encephalomyelitis and Acute disseminated encephalomyelitis.
His scientific interests lie mostly in Internal medicine, Antibody, Immunology, Multiple sclerosis and Cardiology. In his research on the topic of Internal medicine, Differential diagnosis, Cell based assays, Subgroup analysis, Poisson regression and Controlled studies is strongly related with Gastroenterology. His research on Immunology often connects related areas such as NODAL.
His work in the fields of Myelin oligodendrocyte glycoprotein overlaps with other areas such as Translation. Markus Reindl combines subjects such as Carboxyfluorescein diacetate succinimidyl ester, Neuromyelitis optica, Peripheral blood mononuclear cell, Optic neuritis and Acute disseminated encephalomyelitis with his study of Myelin oligodendrocyte glycoprotein. The various areas that he examines in his Neuromyelitis optica study include Primary outcome, Transverse myelitis and Pathology.
Markus Reindl mainly focuses on Multiple sclerosis, Myelin oligodendrocyte glycoprotein, Antibody, Neuromyelitis optica and Optic neuritis. His research in Multiple sclerosis intersects with topics in Disability progression, Olfactory threshold, Neuroscience and Odor identification. Immunology covers Markus Reindl research in Myelin oligodendrocyte glycoprotein.
His Acute disseminated encephalomyelitis and Encephalitis study in the realm of Immunology interacts with subjects such as Serine C-palmitoyltransferase. His work on Immunofluorescence and Autoantibody as part of general Antibody study is frequently linked to Severe acute respiratory syndrome coronavirus 2, therefore connecting diverse disciplines of science. The Neuromyelitis optica study combines topics in areas such as Circumventricular organs, Aquaporin 4, Pathology, Transverse myelitis and Myelitis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A clinical approach to diagnosis of autoimmune encephalitis
Francesc Graus;Maarten J. Titulaer;Ramani Balu;Susanne Benseler.
Lancet Neurology (2016)
Toll-like Receptor 4 Polymorphisms and Atherogenesis
Stefan Kiechl;Eva Lorenz;Markus Reindl;Christian J Wiedermann.
The New England Journal of Medicine (2002)
Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event
Thomas Berger;Paul Rubner;Franz Schautzer;Robert Egg.
The New England Journal of Medicine (2003)
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
Sven Jarius;Klemens Ruprecht;Ingo Kleiter;Nadja Borisow.
Journal of Neuroinflammation (2016)
Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.
Monika Bradl;Tatsuro Misu;Toshiyuki Takahashi;Mitsutoshi Watanabe.
Annals of Neurology (2009)
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.
Simone Mader;Viktoria Gredler;Kathrin Schanda;Kevin Rostasy.
Journal of Neuroinflammation (2011)
Antibody to aquaporin-4 in the Long-Term Course of Neuromyelitis Optica
S Jarius;F Aboul-Enein;P Waters;B Kuenz.
Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
Markus Reindl;Chris Linington;Uschi Brehm;Robert Egg.
Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia
Lisa Fellner;Regina Irschick;Kathrin Schanda;Markus Reindl.
Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.
Maarten J. Titulaer;Maarten J. Titulaer;Romana Höftberger;Romana Höftberger;Takahiro Iizuka;Frank Leypoldt;Frank Leypoldt.
Annals of Neurology (2014)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: